nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimetrexate—DHFR—uterine cervix—vulva cancer	0.256	0.256	CbGeAlD
Trimetrexate—DHFR—urethra—vulva cancer	0.235	0.235	CbGeAlD
Trimetrexate—DHFR—mammalian vulva—vulva cancer	0.224	0.224	CbGeAlD
Trimetrexate—DHFR—vagina—vulva cancer	0.173	0.173	CbGeAlD
Trimetrexate—DHFR—lymph node—vulva cancer	0.112	0.112	CbGeAlD
